Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Eating and swallowing issues, along with meal planning and prep, can become challenging due to MS symptoms such as fatigue and tremors.

Since being diagnosed with multiple sclerosis (MS) in 2018, Blair has emerged as a fierce advocate for those living with ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...

Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

The company is expecting 2025 EPS to range from $15.25 to $16.25, below the $16.33 FactSet consensus. Revenue is expected to decline by a mid-single-digit percent on a constant currency basis, as ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...